Oncology Institute Inc (NASDAQ:TOI) — Market Cap & Net Worth
Market Cap & Net Worth: Oncology Institute Inc (TOI)
Oncology Institute Inc (NASDAQ:TOI) has a market capitalization of $400.93 Million ($400.93 Million) as of August 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #13230 globally and #3215 in its home market, demonstrating a -4.14% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oncology Institute Inc's stock price $4.86 by its total outstanding shares 99982933 (99.98 Million). See Oncology Institute Inc (TOI) capital reinvestment to understand how much of operating cash flow is reinvested back into capital assets.
Oncology Institute Inc Market Cap History: 2020 to 2026
Oncology Institute Inc's market capitalization history from 2020 to 2026. Data shows change from $1.08 Billion to $485.92 Million (-10.61% CAGR).
Index Memberships
Oncology Institute Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.02% | #357 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #1302 of 3165 |
Weight: Oncology Institute Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Oncology Institute Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oncology Institute Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.71x
Oncology Institute Inc's market cap is 0.71 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $1.08 Billion | $187.51 Million | -$14.32 Million | 5.76x | N/A |
| 2021 | $974.83 Million | $203.00 Million | -$10.93 Million | 4.80x | N/A |
| 2022 | $164.97 Million | $252.48 Million | $152.00K | 0.65x | 1085.34x |
| 2023 | $203.97 Million | $324.24 Million | -$83.07 Million | 0.63x | N/A |
| 2024 | $30.89 Million | $393.41 Million | -$64.66 Million | 0.08x | N/A |
| 2025 | $355.94 Million | $502.73 Million | -$60.61 Million | 0.71x | N/A |
Competitor Companies of TOI by Market Capitalization
Companies near Oncology Institute Inc in the global market cap rankings as of August 1, 2026.
Key companies related to Oncology Institute Inc by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #327 globally with a market cap of $80.16 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #905 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #994 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1356 globally with a market cap of $18.52 Billion USD ( RM73.78 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #327 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $402.59 |
| #905 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €44.52 |
| #994 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1356 | IHH Healthcare Bhd | KLSE:5225 | $18.52 Billion | RM8.35 |
Oncology Institute Inc Historical Marketcap From 2020 to 2026
Between 2020 and today, Oncology Institute Inc's market cap moved from $1.08 Billion to $ 485.92 Million, with a yearly change of -10.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $485.92 Million | +36.52% |
| 2025 | $355.94 Million | +1052.10% |
| 2024 | $30.89 Million | -84.85% |
| 2023 | $203.97 Million | +23.64% |
| 2022 | $164.97 Million | -83.08% |
| 2021 | $974.83 Million | -9.72% |
| 2020 | $1.08 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Oncology Institute Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $400.93 Million USD |
| MoneyControl | $400.93 Million USD |
| MarketWatch | $400.93 Million USD |
| marketcap.company | $400.93 Million USD |
| Reuters | $400.93 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Oncology Institute Inc
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as edu… Read more